Treating heart failure patients with anti-obesity medication reduces greenhouse gas emissions and improves clinical outcomes
New research has found that the use of GLP-1 receptor agonists*, a class of medications commonly prescribed for patients with obesity and diabetes, reduces the environmental footprint of […]
